255 related articles for article (PubMed ID: 16773508)
1. Pitfall in metabolic screening in a patient with fatal peroxisomal beta-oxidation defect.
Rosewich H; Waterham HR; Wanders RJ; Ferdinandusse S; Henneke M; Hunneman D; Gärtner J
Neuropediatrics; 2006 Apr; 37(2):95-8. PubMed ID: 16773508
[TBL] [Abstract][Full Text] [Related]
2. Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency.
Ferdinandusse S; Denis S; Hogenhout EM; Koster J; van Roermund CW; IJlst L; Moser AB; Wanders RJ; Waterham HR
Hum Mutat; 2007 Sep; 28(9):904-12. PubMed ID: 17458872
[TBL] [Abstract][Full Text] [Related]
3. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
Paton BC; Sharp PC; Crane DI; Poulos A
J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
[TBL] [Abstract][Full Text] [Related]
4. Straight-chain acyl-CoA oxidase knockout mouse accumulates extremely long chain fatty acids from alpha-linolenic acid: evidence for runaway carousel-type enzyme kinetics in peroxisomal beta-oxidation diseases.
Infante JP; Tschanz CL; Shaw N; Michaud AL; Lawrence P; Brenna JT
Mol Genet Metab; 2002 Feb; 75(2):108-19. PubMed ID: 11855929
[TBL] [Abstract][Full Text] [Related]
5. Peroxisomal acyl-CoA-oxidase deficiency: two new cases.
Carrozzo R; Bellini C; Lucioli S; Deodato F; Cassandrini D; Cassanello M; Caruso U; Rizzo C; Rizza T; Napolitano ML; Wanders RJ; Jakobs C; Bruno C; Santorelli FM; Dionisi-Vici C; Bonioli E
Am J Med Genet A; 2008 Jul; 146A(13):1676-81. PubMed ID: 18536048
[TBL] [Abstract][Full Text] [Related]
6. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
7. Distinction between peroxisomal bifunctional enzyme and acyl-CoA oxidase deficiencies.
Watkins PA; McGuinness MC; Raymond GV; Hicks BA; Sisk JM; Moser AB; Moser HW
Ann Neurol; 1995 Sep; 38(3):472-7. PubMed ID: 7668838
[TBL] [Abstract][Full Text] [Related]
8. Peroxisomes, lipid metabolism, and peroxisomal disorders.
Wanders RJ
Mol Genet Metab; 2004; 83(1-2):16-27. PubMed ID: 15464416
[TBL] [Abstract][Full Text] [Related]
9. Novel ACOX1 mutations in two siblings with peroxisomal acyl-CoA oxidase deficiency.
Morita A; Enokizono T; Ohto T; Tanaka M; Watanabe S; Takada Y; Iwama K; Mizuguchi T; Matsumoto N; Morita M; Takashima S; Shimozawa N; Takada H
Brain Dev; 2021 Mar; 43(3):475-481. PubMed ID: 33234382
[TBL] [Abstract][Full Text] [Related]
10. Neonatal seizures and severe hypotonia in a male infant suffering from a defect in peroxisomal beta-oxidation.
Van Maldergem L; Espeel M; Wanders RJ; Roels F; Gerard P; Scalais E; Mannaerts GP; Casteels M; Gillerot Y
Neuromuscul Disord; 1992; 2(3):217-24. PubMed ID: 1483048
[TBL] [Abstract][Full Text] [Related]
11. Targeted disruption of the peroxisomal thiolase B gene in mouse: a new model to study disorders related to peroxisomal lipid metabolism.
Chevillard G; Clémencet MC; Latruffe N; Nicolas-Francès V
Biochimie; 2004 Nov; 86(11):849-56. PubMed ID: 15589695
[TBL] [Abstract][Full Text] [Related]
12. [Peroxisomal diseases--a survey].
Theron JJ; van Papendorp DH
S Afr Med J; 1996 Jun; 86(6):685-90. PubMed ID: 8764428
[TBL] [Abstract][Full Text] [Related]
13. Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer.
Zha S; Ferdinandusse S; Hicks JL; Denis S; Dunn TA; Wanders RJ; Luo J; De Marzo AM; Isaacs WB
Prostate; 2005 Jun; 63(4):316-23. PubMed ID: 15599942
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers predicting survival in peroxisome biogenesis disorders.
Gootjes J; Mooijer PA; Dekker C; Barth PG; Poll-The BT; Waterham HR; Wanders RJ
Neurology; 2002 Dec; 59(11):1746-9. PubMed ID: 12473763
[TBL] [Abstract][Full Text] [Related]
15. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
[TBL] [Abstract][Full Text] [Related]
16. Pristanic acid does not accumulate in peroxisomal acyl-CoA oxidase deficiency: evidence for a distinct peroxisomal pristanyl-CoA oxidase.
ten Brink HJ; Poll-The BT; Saudubray JM; Wanders RJ; Jakobs C
J Inherit Metab Dis; 1991; 14(5):681-4. PubMed ID: 1779614
[TBL] [Abstract][Full Text] [Related]
17. ACBD5 deficiency causes a defect in peroxisomal very long-chain fatty acid metabolism.
Ferdinandusse S; Falkenberg KD; Koster J; Mooyer PA; Jones R; van Roermund CWT; Pizzino A; Schrader M; Wanders RJA; Vanderver A; Waterham HR
J Med Genet; 2017 May; 54(5):330-337. PubMed ID: 27799409
[TBL] [Abstract][Full Text] [Related]
18. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
Takemoto Y; Suzuki Y; Horibe R; Shimozawa N; Wanders RJ; Kondo N
Brain Dev; 2003 Oct; 25(7):481-7. PubMed ID: 13129591
[TBL] [Abstract][Full Text] [Related]
19. Functional characterisation of peroxisomal β-oxidation disorders in fibroblasts using lipidomics.
Herzog K; Pras-Raves ML; Ferdinandusse S; Vervaart MAT; Luyf ACM; van Kampen AHC; Wanders RJA; Waterham HR; Vaz FM
J Inherit Metab Dis; 2018 May; 41(3):479-487. PubMed ID: 28849344
[TBL] [Abstract][Full Text] [Related]
20. Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry.
Takashima S; Toyoshi K; Itoh T; Kajiwara N; Honda A; Ohba A; Takemoto S; Yoshida S; Shimozawa N
Mol Genet Metab; 2017 Mar; 120(3):255-268. PubMed ID: 28089346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
